Format
Sort by
Items per page

Send to

Choose Destination

Best matches for John S Lambert:

Single Core Genome Sequencing for Detection of both <i>Borrelia burgdorferi</i> Sensu Lato and Relapsing Fever Borrelia Species. Lee SH et al. Int J Environ Res Public Health. (2019)

Clinical focus: infections in pregnancy. Adler H et al. Hosp Pract (1995). (2014)

Daclatasvir for the treatment of hepatitis C virus infection. Adler H et al. Expert Rev Gastroenterol Hepatol. (2014)

Search results

Items: 1 to 20 of 50

1.

HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA.

Avramovic G, Oprea C, Surey J, Story A, Macías J, Cullen W, Iglesias M, Ianache I, Lazar S, Popa I, Menezes D, Lambert JS.

Int J Infect Dis. 2019 Nov 27. pii: S1201-9712(19)30467-9. doi: 10.1016/j.ijid.2019.11.027. [Epub ahead of print]

2.

Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care.

Nic An Riogh E, Swan D, McCombe G, O'Connor E, Avramovic G, Macías J, Oprea C, Story A, Surey J, Vickerman P, Ward Z, Lambert JS, Tinago W, Ianache I, Iglesias M, Cullen W.

J Antimicrob Chemother. 2019 Nov 1;74(Supplement_5):v31-v38. doi: 10.1093/jac/dkz454.

PMID:
31782502
3.

Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series.

McCombe G, Almaazmi B, Cullen W, Lambert JS, Avramovic G, Murphy C, O'Connor M, Perry N, Ianache I, Lazar S, McHugh T, Surey J, Macías J, Vickerman P, Oprea C.

J Antimicrob Chemother. 2019 Nov 1;74(Supplement_5):v24-v30. doi: 10.1093/jac/dkz453.

PMID:
31782501
4.

HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study.

Barror S, Avramovic G, Oprea C, Surey J, Story A, Macías J, Cullen W, Crowley D, Horan A, Naughton AM, Iglesias M, Ianache I, Lazar S, Popa I, McHugh T, Menezes D, Tinago W, Lambert JS.

J Antimicrob Chemother. 2019 Nov 1;74(Supplement_5):v39-v46. doi: 10.1093/jac/dkz455.

PMID:
31782499
5.

Potential Persistent Borrelia Infection and Response to Antibiotic Therapy; a Clinical Case Study and Review of Recent Literature.

Moysa C, Murtagh R, Lambert JS.

Antibiotics (Basel). 2019 Nov 14;8(4). pii: E223. doi: 10.3390/antibiotics8040223.

6.

Correction to: Rapid development of HIV elite control in a patient with acute infection.

Morley D, Lambert JS, Hogan LE, De Gascun C, Redmond N, Rutishauser RL, Thanh C, Gibson EA, Hobbs K, Bakkour S, Busch MP, Farrell J, McGetrick P, Henrich TJ.

BMC Infect Dis. 2019 Oct 22;19(1):877. doi: 10.1186/s12879-019-4485-2.

7.

Rapid development of HIV elite control in a patient with acute infection.

Morley D, Lambert JS, Hogan LE, De Gascun C, Redmond N, Rutishauser RL, Thanh C, Gibson EA, Hobbs K, Bakkour S, Busch MP, Farrell J, McGetrick P, Henrich TJ.

BMC Infect Dis. 2019 Sep 18;19(1):815. doi: 10.1186/s12879-019-4374-8. Erratum in: BMC Infect Dis. 2019 Oct 22;19(1):877.

8.

Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.

Crowley D, Cullen W, Lambert JS, Van Hout MC.

PLoS One. 2019 Sep 11;14(9):e0222186. doi: 10.1371/journal.pone.0222186. eCollection 2019.

9.

Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T, McKiernan S, Miggin SJ, O'Connor E, O'Reilly D, Betts-Symonds G, Tobin C, Van Hout MC, Lambert JS.

Harm Reduct J. 2019 Jul 5;16(1):42. doi: 10.1186/s12954-019-0313-7.

10.

Single Core Genome Sequencing for Detection of both Borrelia burgdorferi Sensu Lato and Relapsing Fever Borrelia Species.

Lee SH, Healy JE, Lambert JS.

Int J Environ Res Public Health. 2019 May 20;16(10). pii: E1779. doi: 10.3390/ijerph16101779.

11.

Metagenomic 16S rRNA gene sequencing survey of Borrelia species in Irish samples of Ixodes ricinus ticks.

Lambert JS, Cook MJ, Healy JE, Murtagh R, Avramovic G, Lee SH.

PLoS One. 2019 Apr 15;14(4):e0209881. doi: 10.1371/journal.pone.0209881. eCollection 2019.

12.

The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.

Crowley D, Lambert JS, Betts-Symonds G, Cullen W, Keevans M, Kelly E, Laird E, McHugh T, McKiernan S, Miggin SJ, Murphy C, Murtagh R, O'Reilly D, Tobin C, Van Hout MC.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800369.

13.

'HepCheck Dublin': an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care.

Lambert JS, Murtagh R, Menezes D, O'Carroll A, Murphy C, Cullen W, McHugh T, Avramovic G, Tinago W, Van Hout MC.

BMC Infect Dis. 2019 Feb 7;19(1):128. doi: 10.1186/s12879-019-3748-2.

14.

Therapeutic drug monitoring of darunavir/ritonavir in pregnancy.

Murtagh R, Else LJ, Kuan KB, Khoo SH, Jackson V, Patel A, Lawler M, McDonald G, Le Blanc D, Avramovic G, Redmond N, Lambert JS.

Antivir Ther. 2019;24(3):229-233. doi: 10.3851/IMP3291.

PMID:
30728322
15.

Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study.

Murtagh R, Swan D, O'Connor E, McCombe G, Lambert JS, Avramovic G, Cullen W.

Interact J Med Res. 2018 Dec 19;7(2):e10313. doi: 10.2196/10313.

16.

Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.

Crowley D, Van Hout MC, Lambert JS, Kelly E, Murphy C, Cullen W.

Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.

17.

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.

McCombe G, Swan D, O'Connor E, Avramovic G, Vickerman P, Ward Z, Surey J, Macías J, Lambert JS, Cullen W.

JMIR Res Protoc. 2018 Jun 4;7(6):e149. doi: 10.2196/resprot.9043.

18.

Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol.

Swan D, Cullen W, Macias J, Oprea C, Story A, Surey J, Vickerman P, Lambert JS.

Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):303-314. doi: 10.1080/17474124.2018.1424541. Epub 2018 Jan 16.

PMID:
29300496
19.

Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Crowley D, Cullen W, Laird E, Lambert JS, Mc Hugh T, Murphy C, Van Hout MC.

J Transl Int Med. 2017 Jun 30;5(2):112-119. doi: 10.1515/jtim-2017-0017. eCollection 2017 Jun.

20.

Experience of dolutegravir in HIV-infected treatment-naive patients from a tertiary care University Hospital in Ireland.

Waqas S, O'Connor M, Levey C, Mallon P, Sheehan G, Patel A, Avramovic G, Lambert JS.

SAGE Open Med. 2016 Oct 25;4:2050312116675813. eCollection 2016.

Supplemental Content

Loading ...
Support Center